The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
Involvement of Members of the Cadherin Superfamily in Cancer
Open accessAbstract
We review the role of cadherins and cadherin-related proteins in human cancer. Cellular and animal models for human cancer are also dealt with whenever appropriate. E-cadherin is the prototype of the large cadherin superfamily and is renowned for its potent malignancy suppressing activity. Different mechanisms for inactivating E-cadherin/CDH1 have been identified in human cancers: inherited and somatic mutations, aberrant protein processing, increased promoter methylation, and induction of transcriptional repressors such as Snail and ZEB family members. The latter induce epithelial mesenchymal transition, which is also associated with induction of "mesenchymal" cadherins, a hallmark of tumor progression. VE-cadherin/CDH5 plays a role in tumor-associated angiogenesis. The atypical T-cadherin/CDH13 is often silenced in cancer cells but up-regulated in tumor vasculature. The review also covers the status of protocadherins and several other cadherin-related molecules in human cancer. Perspectives for emerging cadherin-related anticancer therapies are given.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
Vascular Channel Formation by Human Melanoma Cells in Vivo and in Vitro: Vasculogenic Mimicry
Maniotis, A. J., Folberg, R., Hess, A., Seftor, E. A., Gardner, L. M. G., Pe'er, J., Trent, J. M., Meltzer, P. S., & Hendrix, M. J. C. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65173-5 · Cited by 2,043
Molecular classification of cutaneous malignant melanoma by gene expression profiling
Bittner, M., Meltzer, P., Chen, Y., Jiang, Y., Seftor, E., Hendrix, M., Radmacher, M., Simon, R., Yakhini, Z., Ben-Dor, A., et al. (2000) · Nature · doi:10.1038/35020115 · Cited by 1,990
Burk, U., Schubert, J., Wellner, U., Schmalhofer, O., Vincan, E., Spaderna, S., & Brabletz, T. (2008) · EMBO reports · doi:10.1038/embor.2008.74 · Cited by 1,722
Vleminckx, K., Vakaet, L., Mareel, M., Fiers, W., & Van Roy, F. (1991) · Cell · doi:10.1016/0092-8674(91)90143-m · Cited by 1,656
E-cadherin germline mutations in familial gastric cancer
Guilford, P., Hopkins, J., Harraway, J., McLeod, M., McLeod, N., Harawira, P., Taite, H., Scoular, R., Miller, A., & Reeve, A. E. (1998) · Nature · doi:10.1038/32918 · Cited by 1,656
Korpal, M., Lee, E. S., Hu, G., & Kang, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800074200 · Cited by 1,645
Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
Morel, A.-P., Lièvre, M., Thomas, C., Hinkal, G., Ansieau, S., & Puisieux, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002888 · Cited by 1,645
E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.
Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Löchner, D., & Birchmeier, W. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.1.173 · Cited by 1,551
A causal role for E-cadherin in the transition from adenoma to carcinoma
Perl, A.-K., Wilgenbus, P., Dahl, U., Semb, H., & Christofori, G. (1998) · Nature · doi:10.1038/32433 · Cited by 1,424
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
Ley, T. J., Mardis, E. R., Ding, L., Fulton, B., McLellan, M. D., Chen, K., Dooling, D., Dunford-Shore, B. H., McGrath, S., Hickenbotham, M., et al. (2008) · Nature · doi:10.1038/nature07485 · Cited by 1,422
The cell-cell adhesion molecule E-cadherin
van Roy, F., & Berx, G. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8281-1 · Cited by 1,325
Self-citationmultifunctional enzymes in cancer
Mohamed, M. M., & Sloane, B. F. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1949 · Cited by 1,265
Endothelial cell–cell junctions: happy together
Dejana, E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1357 · Cited by 1,188
Bracken, C. P., Gregory, P. A., Kolesnikoff, N., Bert, A. G., Wang, J., Shannon, M. F., & Goodall, G. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1942 · Cited by 1,060
Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype
Sarrió, D., Rodriguez-Pinilla, S. M., Hardisson, D., Cano, A., Moreno-Bueno, G., & Palacios, J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2017 · Cited by 1,056
BIRCHMEIER, W., & BEHRENS, J. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90003-5 · Cited by 1,002
Hazan, R. B., Phillips, G. R., Qiao, R. F., Norton, L., & Aaronson, S. A. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.4.779 · Cited by 933
Multiple loci identified in a genome-wide association study of prostate cancer
Thomas, G., Jacobs, K. B., Yeager, M., Kraft, P., Wacholder, S., Orr, N., Yu, K., Chatterjee, N., Welch, R., Hutchinson, A., et al. (2008) · Nature Genetics · doi:10.1038/ng.91 · Cited by 900
Pathogenetic mechanisms in thyroid follicular-cell neoplasia
Kondo, T., Ezzat, S., & Asa, S. L. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1836 · Cited by 893
Characterization of microRNA expression profiles in normal human tissues.
Liang, Y., Ridzon, D., Wong, L., & Chen, C. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-166 · Cited by 881
T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin
Hug, C., Wang, J., Ahmad, N. S., Bogan, J. S., Tsao, T.-S., & Lodish, H. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403382101 · Cited by 859
Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex
Fujita, Y., Krause, G., Scheffner, M., Zechner, D., Leddy, H. E. M., Behrens, J., Sommer, T., & Birchmeier, W. (2002) · Nature Cell Biology · doi:10.1038/ncb758 · Cited by 846
Eger, A., Aigner, K., Sonderegger, S., Dampier, B., Oehler, S., Schreiber, M., Berx, G., Cano, A., Beug, H., & Foisner, R. (2005) · Oncogene · doi:10.1038/sj.onc.1208429 · Cited by 808
Self-citationE-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
Graff, J. R., Herman, J. G., Lapidus, R. G., Chopra, H., Xu, R., Jarrard, D. F., Isaacs, W. B., Pitha, P. M., Davidson, N. E., & Baylin, S. B. (1995) · PubMed · Cited by 796
N-Cadherin Promotes Motility in Human Breast Cancer Cells Regardless of Their E-Cadherin Expression
Nieman, M. T., Prudoff, R. S., Johnson, K. R., & Wheelock, M. J. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.3.631 · Cited by 789
E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.
Berx, G., Cleton-Jansen, A. M., Nollet, F., de Leeuw, W. J., van de Vijver, M., Cornelisse, C., & van Roy, F. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00301.x · Cited by 775
Self-citationCadherins and cancer: how does cadherin dysfunction promote tumor progression?
Jeanes, A., Gottardi, C. J., & Yap, A. S. (2008) · Oncogene · doi:10.1038/onc.2008.343 · Cited by 772
E-cadherin gene mutations provide clues to diffuse type gastric carcinomas.
Becker, K., Atkinson, M. J., Reich, U., Becker, I., Nekarda, H., Siewert, J. R., & Höfler, H. (1994) · PubMed · Cited by 767
Wheelock, M. J., Shintani, Y., Maeda, M., Fukumoto, Y., & Johnson, K. R. (2008) · Journal of Cell Science · doi:10.1242/jcs.000455 · Cited by 767
The transcriptional repressor Snail promotes mammary tumor recurrence
Moody, S. E., Perez, D., Pan, T.-C., Sarkisian, C. J., Portocarrero, C. P., Sterner, C. J., Notorfrancesco, K. L., Cardiff, R. D., & Chodosh, L. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.07.009 · Cited by 750
The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene
Christofori, G., & Semb, H. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01343-7 · Cited by 742
Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1
Noë, V., Fingleton, B., Jacobs, K., Crawford, H. C., Vermeulen, S., Steelant, W., Bruyneel, E., Matrisian, L. M., & Mareel, M. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.1.111 · Cited by 695
Lochter, A., Galosy, S., Muschler, J., Freedman, N., Werb, Z., & Bissell, M. J. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.7.1861 · Cited by 655
Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas.
Yoshiura, K., Kanai, Y., Ochiai, A., Shimoyama, Y., Sugimura, T., & Hirohashi, S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7416 · Cited by 645
Pharoah, P. D. P., Guilford, P., & Caldas, C. (2001) · Gastroenterology · doi:10.1053/gast.2001.29611 · Cited by 638
The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network
Harvey, K., & Tapon, N. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2070 · Cited by 628
Mutations of the human E-cadherin (CDH1) gene
Berx, G., Becker, K.-F., Höfler, H., & van Roy, F. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)12:4<226::aid-humu2>3.0.co;2-d · Cited by 607
Self-citationCadherin Switch in Tumor Progression
HAZAN, R. B., QIAO, R., KEREN, R., BADANO, I., & SUYAMA, K. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.016 · Cited by 595
DNA Methylation Markers and Early Recurrence in Stage I Lung Cancer
Brock, M. V., Hooker, C. M., Ota-Machida, E., Han, Y., Guo, M., Ames, S., Glöckner, S., Piantadosi, S., Gabrielson, E., Pridham, G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706550 · Cited by 593
Derksen, P. W. B., Liu, X., Saridin, F., van der Gulden, H., Zevenhoven, J., Evers, B., van Beijnum, J. R., Griffioen, A. W., Vink, J., Krimpenfort, P., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.09.013 · Cited by 591
Correlation of Snail expression with histological grade and lymph node status in breast carcinomas
Blanco, M. J., Moreno-Bueno, G., Sarrio, D., Locascio, A., Cano, A., Palacios, J., & Nieto, M. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205416 · Cited by 576
Rosivatz, E., Becker, I., Specht, K., Fricke, E., Luber, B., Busch, R., Höfler, H., & Becker, K.-F. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64464-1 · Cited by 572
Distinct roles for cysteine cathepsin genes in multistage tumorigenesis
Gocheva, V., Zeng, W., Ke, D., Klimstra, D., Reinheckel, T., Peters, C., Hanahan, D., & Joyce, J. A. (2006) · Genes & Development · doi:10.1101/gad.1407406 · Cited by 570
SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions
Vandewalle, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki965 · Cited by 542
Ovarian Cancer Metastasis: Integrating insights from disparate model organisms
Naora, H., & Montell, D. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1611 · Cited by 538
The Transcriptional Repressor ZEB1 Promotes Metastasis and Loss of Cell Polarity in Cancer
Spaderna, S., Schmalhofer, O., Wahlbuhl, M., Dimmler, A., Bauer, K., Sultan, A., Hlubek, F., Jung, A., Strand, D., Eger, A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5682 · Cited by 532
Loss of Fat4 disrupts PCP signaling and oriented cell division and leads to cystic kidney disease
Saburi, S., Hester, I., Fischer, E., Pontoglio, M., Eremina, V., Gessler, M., Quaggin, S. E., Harrison, R., Mount, R., & McNeill, H. (2008) · Nature Genetics · doi:10.1038/ng.179 · Cited by 525
A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor
Suyama, K., Shapiro, I., Guttman, M., & Hazan, R. B. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00150-2 · Cited by 515
Familial gastric cancer: overview and guidelines for management.
Caldas, C. H., Carneiro, F., Lynch, H. T., et al. (1999) · PubMed · Cited by 508
Guaita, S., Puig, I., Francı́, C., Garrido, M., Domı́nguez, D., Batlle, E., Sancho, E., Dedhar, S., de Herreros, A. G., & Baulida, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206400200 · Cited by 499
Molecular evolution of the cadherin superfamily
Hulpiau, P., & van Roy, F. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.09.027 · Cited by 498
Self-citationYauch, R. L., Januario, T., Eberhard, D. A., Cavet, G., Zhu, W., Fu, L., Pham, T. Q., Soriano, R., Stinson, J., Seshagiri, S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1492 · Cited by 495
E‐cadherin is essential for in vivo epidermal barrier function by regulating tight junctions
Tunggal, J. A., Helfrich, I., Schmitz, A., Schwarz, H., Günzel, D., Fromm, M., Kemler, R., Krieg, T., & Niessen, C. M. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600605 · Cited by 491 · cited 2×
“In contrast, in mouse models specific loss of E-cadherin in the skin and the mammary gland is not sufficient for tumorigenesis (Boussadia et al. 2002; Tinkle et al. 2004; Tunggal et al. 2005).”
BackgroundMartin, T. A., Goyal, A., Watkins, G., & Jiang, W. G. (2005) · Annals of Surgical Oncology · doi:10.1245/aso.2005.04.010 · Cited by 486
Spaderna, S., Schmalhofer, O., Hlubek, F., Berx, G., Eger, A., Merkel, S., Jung, A., Kirchner, T., & Brabletz, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.06.016 · Cited by 476
Self-citationMarambaud, P., Wen, P. H., Dutt, A., Shioi, J., Takashima, A., Siman, R., & Robakis, N. K. (2003) · Cell · doi:10.1016/j.cell.2003.08.008 · Cited by 464
Berx, G., Cleton-Jansen, A., Strumane, K., de Leeuw, W. J., Nollet, F., Roy, F. M. V., & Cornelisse, C. J. (1996) · PubMed · Cited by 461
Self-citationHendrix, M. J. C., Seftor, E. A., Meltzer, P. S., Gardner, L. M. G., Hess, A. R., Kirschmann, D. A., Schatteman, G. C., & Seftor, R. E. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131209798 · Cited by 456
The Hippo–YAP pathway: new connections between regulation of organ size and cancer
Zhao, B., Lei, Q.-Y., & Guan, K.-L. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.10.001 · Cited by 455
Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer
Grady, W. M., Willis, J., Guilford, P. J., Dunbier, A. K., Toro, T. T., Lynch, H., Wiesner, G., Ferguson, K., Eng, C., Park, J.-G., et al. (2000) · Nature Genetics · doi:10.1038/79120 · Cited by 447
Zeng, Q., & Hong, W. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.011 · Cited by 435
Elloul, S., Bukholt Elstrand, M., Nesland, J. M., Tropé, C. G., Kvalheim, G., Goldberg, I., Reich, R., & Davidson, B. (2005) · Cancer · doi:10.1002/cncr.20946 · Cited by 429
Cadherin switching in human prostate cancer progression.
Tomita, K., van Bokhoven, A., van Leenders, G. J. L. H., Ruijter, E. T. G., Jansen, C. F. J., Bussemakers, M. J. G., & Schalken, J. A. (2000) · PubMed · Cited by 425
Maruyama, R., Toyooka, S., Toyooka, K. O., Harada, K., Virmani, A. K., Zöchbauer‐Müller, S., Farinas, A. J., Vakar‐Lopez, F., Minna, J. D., Sagalowsky, A. I., et al. (2001) · PubMed · Cited by 422
Krishnamachary, B., Zagzag, D., Nagasawa, H., Rainey, K., Okuyama, H., Baek, J. H., & Semenza, G. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3719 · Cited by 415
Graff, J. R., Gabrielson, E., Fujii, H., Baylin, S. B., & Herman, J. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2727 · Cited by 393
Hurteau, G. J., Carlson, J. A., Spivack, S. D., & Brock, G. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1058 · Cited by 390
Brooks-Wilson, A. R., Kaurah, P., Suriano, G., Leach, S., Senz, J., Grehan, N., Butterfield, Y. S. N., Jeyes, J., Schinas, J., Bacani, J., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.018275 · Cited by 361
Lombaerts, M., van Wezel, T., Philippo, K., Dierssen, J. W. F., Zimmerman, R. M. E., Oosting, J., van Eijk, R., Eilers, P. H., van de Water, B., Cornelisse, C. J., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602996 · Cited by 346
Gordon, M. S. (2007) · Yearbook of Oncology · doi:10.1016/s1040-1741(08)70352-x · Cited by 346
Ranscht, B., & Dours-Zimmermann, M. T. (1991) · Neuron · doi:10.1016/0896-6273(91)90291-7 · Cited by 329
Nass, S. J., Herman, J. G., Gabrielson, E. W., Iversen, P. W., Parl, F. F., Davidson, N. E., & Graff, J. R. (2000) · PubMed · Cited by 292
Ying, J., Li, H., Seng, T. J., Langford, C., Srivastava, G., Tsao, S. W., Putti, T., Murray, P., Chan, A. T. C., & Tao, Q. (2006) · Oncogene · doi:10.1038/sj.onc.1209154 · Cited by 281
Mutations of the E–cadherin gene in human gynecologic cancers
Risinger, J. I., Berchuck, A., Kohler, M. F., & Boyd, J. (1994) · Nature Genetics · doi:10.1038/ng0594-98 · Cited by 280
E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma
Machado, J. C., Oliveira, C., Carvalho, R., Soares, P., Berx, G., Caldas, C., Seruca, R., Carneiro, F., & Sobrinho-Simöes, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204234 · Cited by 278
Self-citationLopez, T., & Hanahan, D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00055-7 · Cited by 268
Regulation of E-cadherin Expression by VHL and Hypoxia-Inducible Factor
Esteban, M. A., Tran, M. G. B., Harten, S. K., Hill, P., Castellanos, M. C., Chandra, A., Raval, R., O'Brien, T. S., & Maxwell, P. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2670 · Cited by 262
Paredes, J., Albergaria, A., Oliveira, J. T., Jerónimo, C., Milanezi, F., & Schmitt, F. C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0059 · Cited by 257
E-cadherin is a survival factor for the lactating mouse mammary gland
Boussadia, O., Kutsch, S., Hierholzer, A., Delmas, V., & Kemler, R. (2002) · Mechanisms of Development · doi:10.1016/s0925-4773(02)00090-4 · Cited by 248
VHL Promotes E2 Box-Dependent E-Cadherin Transcription by HIF-Mediated Regulation of SIP1 and Snail
Evans, A. J., Russell, R. C., Roche, O., Burry, T. N., Fish, J. E., Chow, V. W. K., Kim, W. Y., Saravanan, A., Maynard, M. A., Gervais, M. L., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00892-06 · Cited by 248
Self-citationToyooka, K. O., Toyooka, S., Virmani, A. K., Sathyanarayana, U. G., Euhus, D., Gilcrease, M. Z., Minna, J. D., & Gazdar, A. F. (2001) · PubMed · Cited by 243
Cancer phenomics: RET and PTEN as illustrative models
Zbuk, K. M., & Eng, C. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2037 · Cited by 239
Cadherin-11 is expressed in invasive breast cancer cell lines.
Pishvaian, M. J., Feltes, C. M., Thompson, P., Bussemakers, M. J. G., Schalken, J. A., & Byers, S. W. (1999) · PubMed · Cited by 238
Symowicz, J., Adley, B. P., Gleason, K. J., Johnson, J. J., Ghosh, S., Fishman, D. A., Hudson, L. G., & Stack, M. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2808 · Cited by 235
N-Cadherin Promotes Adhesion Between Invasive Breast Cancer Cells and the Stroma
Hazan, R. B., Kang, L., Whooley, B. P., & Borgen, P. I. (1997) · Cell Adhesion and Communication · doi:10.3109/15419069709004457 · Cited by 231
Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast
Droufakou, S., Deshmane, V., Roylance, R., Hanby, A., Tomlinson, I., & Hart, I. R. (2001) · International Journal of Cancer · doi:10.1002/ijc.1208 · Cited by 229
Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer
Berx, G., Raspé, E., Christofori, G., Thiery, J. P., & Sleeman, J. P. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9114-6 · Cited by 226
Self-citationCheng, C.-W., Wu, P.-E., Yu, J.-C., Huang, C.-S., Yue, C.-T., Wu, C.-W., & Shen, C.-Y. (2001) · Oncogene · doi:10.1038/sj.onc.1204505 · Cited by 221
Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1)
Berx, G., Staes, K., van Hengel, J., Molemans, F., Bussemakers, M. J. G., van Bokhoven, A., & van Roy, F. (1995) · Genomics · doi:10.1016/0888-7543(95)80212-5 · Cited by 221
Self-citationHulit, J., Suyama, K., Chung, S., Keren, R., Agiostratidou, G., Shan, W., Dong, X., Williams, T. M., Lisanti, M. P., Knudsen, K., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3401 · Cited by 218
Persistent E-Cadherin Expression in Inflammatory Breast Cancer
Kleer, C. G., van Golen, K. L., Braun, T., & Merajver, S. D. (2001) · Modern Pathology · doi:10.1038/modpathol.3880334 · Cited by 214
Lee, S. W. (1996) · Nature Medicine · doi:10.1038/nm0796-776 · Cited by 214
Yu, J., Cheng, Y. Y., Tao, Q., Cheung, K. F., Lam, C. N. Y., Geng, H., Tian, L., Wong, Y. P., Tong, J. H. M., Ying, J., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.050 · Cited by 209
Corada, M., Zanetta, L., Orsenigo, F., Breviario, F., Lampugnani, M. G., Bernasconi, S., Liao, F., Hicklin, D. J., Bohlen, P., & Dejana, E. (2002) · Blood · doi:10.1182/blood.v100.3.905 · Cited by 195
Identification of 20 genes aberrantly methylated in human breast cancers
Miyamoto, K., Fukutomi, T., Akashi‐Tanaka, S., Hasegawa, T., Asahara, T., Sugimura, T., & Ushijima, T. (2005) · International Journal of Cancer · doi:10.1002/ijc.21054 · Cited by 194
Tinkle, C. L., Lechler, T., Pasolli, H. A., & Fuchs, E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307437100 · Cited by 193
The Ectodomain Shedding of E-cadherin by ADAM15 Supports ErbB Receptor Activation
Najy, A. J., Day, K. C., & Day, M. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801329200 · Cited by 193
Yasuda, S., Tanaka, H., Sugiura, H., Okamura, K., Sakaguchi, T., Tran, U., Takemiya, T., Mizoguchi, A., Yagita, Y., Sakurai, T., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.020 · Cited by 193
Epigenetic versus genetic alterations in the inactivation of E-cadherin
Strathdee, G. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00057-3 · Cited by 192
Cadherin Switching in Human Prostate Cancer Progression
Schalken, J. A. (2000) · The Japanese Journal of Urology · doi:10.5980/jpnjurol.91.92 · Cited by 191
Germline E-cadherin mutations in familial lobular breast cancer
Masciari, S., Larsson, N., Senz, J., Boyd, N., Kaurah, P., Kandel, M. J., Harris, L. N., Pinheiro, H. C., Troussard, A., Miron, P., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.051268 · Cited by 190
Taniuchi, K., Nakagawa, H., Hosokawa, M., Nakamura, T., Eguchi, H., Ohigashi, H., Ishikawa, O., Katagiri, T., & Nakamura, Y. (2005) · Cancer Research · doi:10.1158/0008.5472.can-04-3646 · Cited by 189
Separating the adhesive and signaling functions of the Fat and Dachsous protocadherins
Matakatsu, H., & Blair, S. S. (2006) · Development · doi:10.1242/dev.02401 · Cited by 189
Cadherin-11 Promotes the Metastasis of Prostate Cancer Cells to Bone
Chu, K., Cheng, C.-J., Ye, X., Lee, Y.-C., Zurita, A. J., Chen, D.-T., Yu-Lee, L.-Y., Zhang, S., Yeh, E. T., Hu, M. C.-T., et al. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0077 · Cited by 188
Lubensky, I. A., Gnarra, J. R., Bertheau, P., Walther, M. M., Linehan, W. M., & Zhuang, Z. (1996) · PubMed Central · Cited by 187
Okazaki, N. (2002) · Carcinogenesis · doi:10.1093/carcin/23.7.1139 · Cited by 177
miR-200b mediates post-transcriptional repression of ZFHX1B
Christoffersen, N. R., Silahtaroglu, A., Ørom, U. A., Kauppinen, S., & Lund, A. H. (2007) · RNA · doi:10.1261/rna.586807 · Cited by 175
Davies, G., Jiang, W. G., & Mason, M. D. (2001) · PubMed · Cited by 169
The H-cadherin ( CDH13 ) gene is inactivated in human lung cancer
Sato, M., Mori, Y., Sakurada, A., Fujimura, S., & Horii, A. (1998) · Human Genetics · doi:10.1007/s004390050790 · Cited by 167
Hebbard, L. W., Garlatti, M., Young, L. J. T., Cardiff, R. D., Oshima, R. G., & Ranscht, B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2953 · Cited by 166
Anders, J., Kjær, S., & Ibáñez, C. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104968200 · Cited by 163
Genetics, Pathology, and Clinics of Familial Gastric Cancer
Oliveira, C., Seruca, R., & Carneiro, F. (2006) · International Journal of Surgical Pathology · doi:10.1177/106689690601400105 · Cited by 162
Vestal, D. J., & Ranscht, B. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.2.451 · Cited by 159
δ-Protocadherins: unique structures and functions
Redies, C., Vanhalst, K., & Roy, F. M. V. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5320-z · Cited by 157
δ-Protocadherins: a gene family expressed differentially in the mouse brain
Vanhalst, K., Kools, P., Staes, K., Roy, F. M. V., & Redies, C. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5021-7 · Cited by 156
Crosstalk between the Androgen Receptor and β-Catenin in Castrate-Resistant Prostate Cancer
Wang, G., Wang, J., & Sadar, M. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1718 · Cited by 155
A novel human xenograft model of inflammatory breast cancer.
Alpaugh, M. L., Tomlinson, J. S., Shao, Z. M., et al. (1999) · PubMed · Cited by 153
Paraxial protocadherin coordinates cell polarity during convergent extension via Rho A and JNK
Unterseher, F., Hefele, J. A., Giehl, K., Robertis, E. M. D., Wedlich, D., & Schambony, A. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600332 · Cited by 152
Graff, J. R., Greenberg, V. L., Herman, J. G., Westra, W. H., Boghaert, E. R., Ain, K. B., Saji, M., Zeiger, M. A., Zimmer, S. G., & Baylin, S. B. (1998) · PubMed · Cited by 148
Kallikrein 6 Induces E-Cadherin Shedding and Promotes Cell Proliferation, Migration, and Invasion
Klucky, B., Mueller, R., Vogt, I., Teurich, S., Hartenstein, B., Breuhahn, K., Flechtenmacher, C., Angel, P. E., & Heß, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0607 · Cited by 145
Endothelial cadherins and tumor angiogenesis
Cavallaro, U., Liebner, S., & Dejana, E. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.09.019 · Cited by 144
Neben, K., Korshunov, A., Benner, A., Wrobel, G., Hahn, M., Kokocinski, F., Голанов, А. В., Joos, S., & Lichter, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3968 · Cited by 144
Sanders, D., Blessing, K., Hassan, G. A., Bruton, R., Marsden, J., & Jankowski, J. A. (1999) · Molecular Pathology · doi:10.1136/mp.52.3.151 · Cited by 138
PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer
Yu, J. S., Koujak, S., Nagase, S., Li, C. M., Su, T., Wang, X., Keniry, M. E., Memeo, L., Rojtman, A. D., MANSUKHANI, M. M., et al. (2008) · Oncogene · doi:10.1038/onc.2008.101 · Cited by 134
Philippova, M., Ivanov, D., Joshi, M. B., Kyriakakis, E., Rupp, K., Afonyushkin, T., Bochkov, V., Erné, P., & Resink, T. J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00157-08 · Cited by 130
Cell adhesion and drug resistance in cancer
Croix, B. S., & Kerbel, R. S. (1997) · Current Opinion in Oncology · doi:10.1097/00001622-199711000-00010 · Cited by 129
Schweizer, L., Rizzo, C. A., Spires, T. E., Platero, J. S., Wu, Q., Lin, T.-A., Gottardis, M. M., & Attar, R. M. (2008) · BMC Cell Biology · doi:10.1186/1471-2121-9-4 · Cited by 129
Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas.
Toyooka, S., Toyooka, K. O., Harada, K., Miyajima, K., Makarla, P., Sathyanarayana, U. G., Yin, J., Sato, F., Shivapurkar, N., Meltzer, S. J., et al. (2002) · PubMed · Cited by 129
Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E‐cadherin
Johnson, S., Ramani, V. C., Hennings, L. J., & Haun, R. S. (2007) · Cancer · doi:10.1002/cncr.22606 · Cited by 128
Soluble cadherins as cancer biomarkers
Wever, O. D., Derycke, L., Hendrix, A., Meerleer, G. D., Godeau, F., Depypere, H. T., & Bracke, M. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9104-8 · Cited by 126
Conservation of PCDHX in mammals; expression of human X/Y genes predominantly in brain
Blanco, P., Sargent, C. A., Boucher, C. A., Mitchell, M. J., & Affara, N. A. (2000) · Mammalian Genome · doi:10.1007/s003350010177 · Cited by 126
P-cadherin expression in breast cancer: a review
Paredes, J., Correia, A. L., Ribeiro, A. S., Albergaria, A., Milanezi, F., & Schmitt, F. C. (2007) · Breast Cancer Research · doi:10.1186/bcr1774 · Cited by 125
Chang, H. W., Chow, V., Lam, A. K.-Y., Wei, W., & Yuen, A. P. W. (2002) · Cancer · doi:10.1002/cncr.10211 · Cited by 125
TGF-β antagonists: Why suppress a tumor suppressor?
Akhurst, R. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15970 · Cited by 124
Sundfeldt, K. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(03)00068-6 · Cited by 122
N-cadherin as a therapeutic target in cancer
Mariotti, A., Perotti, A., Sessa, C., & Rüegg, C. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.4.451 · Cited by 122
Shen, Y., Hirsch, D. S., Sasiela, C. A., & Wu, W. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703300200 · Cited by 121
Takeuchi, T., Adachi, Y., Ohtsuki, Y., & Furihata, M. (2007) · Medical Molecular Morphology · doi:10.1007/s00795-007-0364-9 · Cited by 118
Imoto, I., Izumi, H., Yokoi, S., Hosoda, H., Shibata, T., Hosoda, F., Ohki, M., Hirohashi, S., & Inazawa, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4437 · Cited by 113
Yang, X., Chen, M.-W., Terry, S., Vacherot, F., Chopin, D. K., Bemis, D. L., Kitajewski, J., Benson, M. C., Guo, Y., & Buttyan, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0162 · Cited by 111
Placencio, V. R., Sharif‐Afshar, A., Li, X., Huang, H., Uwamariya, C., Neilson, E. G., Shen, M. M., Matusik, R. J., Hayward, S. W., & Bhowmick, N. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6289 · Cited by 110
Frequent Aberrant Methylation of the CDH4 Gene Promoter in Human Colorectal and Gastric Cancer
Miotto, E., Sabbioni, S., Veronese, A., Calin, G. A., Gullini, S., Liboni, A., Gramantieri, L., Bolondi, L., Ferrazzí, E., Gafà, R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-3000 · Cited by 110
Kanai, Y., Ushijima, S., Tsuda, H., Sakamoto, M., & Hirohashi, S. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00316-x · Cited by 108
Epigenetic Silencing of the Protocadherin Family Member PCDH-γ-All in Astrocytomas
Waha, A., Güntner, S., Huang, T. H. ‐., Yan, P. S., Arslan, B., Pietsch, T., Wiestler, O. D., & Waha, A. (2005) · Neoplasia · doi:10.1593/neo.04490 · Cited by 107
Wu, Y., Starzinski‐Powitz, A., & Guo, S. (2007) · Reproductive Sciences · doi:10.1177/1933719107302913 · Cited by 105
Identification of Fat4 as a candidate tumor suppressor gene in breast cancers
Qi, C., Zhu, Y. T., Zhu, Y., & Zhu, Y. (2008) · International Journal of Cancer · doi:10.1002/ijc.23775 · Cited by 104
P-Cadherin Promotes Cell-Cell Adhesion and Counteracts Invasion in Human Melanoma
Marck, V. V., Stove, C. P., Bossche, K. V. D., Stove, V. V., Paredes, J., Haeghen, Y. V., & Bracke, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4414 · Cited by 103
Carneiro, F., Oliveíra, C., Suriano, G., & Seruca, R. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.043679 · Cited by 98
Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14)
Covington, M. D., Burghardt, R. C., & Parrish, A. R. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00179.2005 · Cited by 98
May, C., Doody, J. F., Abdullah, R., Balderes, P. J., Xu, X., Chen, C. P., Zhu, Z., Shapiro, L. S., Kussie, P. H., Hicklin, D. J., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0010 · Cited by 94
Natt, E., Magenis, R. E., Zimmer, J., Mansouri, A., & Scherer, G. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000132745 · Cited by 92
E-cadherin gene alterations are rare events in thyroid tumors
Soares, P., Berx, G., Roy, F. M. V., & Sobrinho-Simões, M. A. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970106)70:1<32::aid-ijc5>3.0.co;2-7 · Cited by 89
Self-citationHuang, Z., Wu, Y., Hedrick, N., & Gutmann, D. H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.566-578.2003 · Cited by 82
Increased expression of H/T-cadherin in tumor-penetrating blood vessels.
Wyder, L., Vitaliti, A., Schneider, H., Hebbard, L., Moritz, D. R., Wittmer, M., Ajmo, M., & Klemenz, R. (2000) · PubMed · Cited by 81
Koizume, S., Tachibana, K., Sekiya, T., Hirohashi, S., & Shiraishi, M. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf593 · Cited by 79
Diverse functions of p120ctn in tumors
van Hengel, J., & Roy, F. M. V. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.08.033 · Cited by 78
Ghosh, S., Joshi, M. B., Ivanov, D., Feder‐Mengus, C., Spagnoli, G. C., Martín, I., Erné, P., & Resink, T. J. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.08.038 · Cited by 78
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
Simões‐Correia, J., Figueiredo, J., Oliveíra, C., van Hengel, J., Seruca, R., Roy, F. M. V., & Suriano, G. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn249 · Cited by 69
Wang, X.-D., Wang, B.-E., Soriano, R. H., Zha, J., Zhang, Z., Modrusan, Z. D., Cunha, G. R., & Gao, W. (2006) · Differentiation · doi:10.1111/j.1432-0436.2006.00135.x · Cited by 67
Chen, M., Vacherot, F., TAILLE, A. D. L., de Medina, S. G. D., Shen, R., Friedman, R. A., Burchardt, M., Chopin, D. K., & Buttyan, R. (2002) · Oncogene · doi:10.1038/sj.onc.1205991 · Cited by 65
Remodeling of Endothelial Adherens Junctions by Kaposi's Sarcoma-Associated Herpesvirus
Mansouri, M., Rose, P. P., Moses, A. V., & Früh, K. (2008) · Journal of Virology · doi:10.1128/jvi.02633-07 · Cited by 65
Development of targeted angiogenic medicine
Loges, S., Roncal, C., & Carmeliet, P. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03203.x · Cited by 62
Vécsey-Semjén, B., Becker, K., Sinski, A., Blennow, E., Vietor, I., Zatloukal, K., Beug, H., Wagner, E., & Huber, L. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205577 · Cited by 61
Riou, P., Saffroy, R., Chenailler, C., Franc, B., Gentile, C., Rubinstein, E., Resink, T. J., Debuire, B., Piatier‐Tonneau, D., & Lemoine, A. (2006) · The FASEB Journal · doi:10.1096/fj.06-6085com · Cited by 60
Frequent promoter methylation and gene silencing of CDH13 in pancreatic cancer
Sakai, M., Hibi, K., Koshikawa, K., Inoue, S., Takeda, S., Kaneko, T., & Nakao, A. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02491.x · Cited by 58
Strumane, K., Berx, G., & Roy, F. M. V. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-68170-0_4 · Cited by 56
Self-citationSrc, chemoresistance and epithelial to mesenchymal transition: are they related?
Shah, A. N., & Gallick, G. E. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32801265d7 · Cited by 54
Ying, J., Gao, Z., Li, H., Srivastava, G., Murray, P. G., Goh, H. K., Lim, C. Y., Wang, Y., Marafioti, T., Mason, D. Y., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06512.x · Cited by 54
Adachi, Y., Takeuchi, T., Sonobe, H., & Ohtsuki, Y. (2005) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-005-0098-9 · Cited by 49
E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus
Wijnhoven, B. P. L., Both, N. J. D., van Dekken, H., Tilanus, H. W., & Dinjens, W. N. M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690577 · Cited by 45
Saito, T., Oda, Y., Sugimachi, K., Kawaguchi, K.-I., Tamiya, S., Tanaka, K., Matsuda, S., Sakamoto, A., Iwamoto, Y., & Tsuneyoshi, M. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63063-5 · Cited by 45
Hereditary diffuse gastric cancer
Dunbier, A. K., & Guilford, P. (2001) · Advances in cancer research · doi:10.1016/s0065-230x(01)83002-5 · Cited by 44
Protocadherin-PC promotes androgen-independent prostate cancer cell growth
Terry, S., Queires, L. C. S., de Medina, S. G. D., Chen, M., TAILLE, A. D. L., Allory, Y., Tran, P.-L., Abbou, C. C., Buttyan, R., & Vacherot, F. (2006) · The Prostate · doi:10.1002/pros.20446 · Cited by 41
The E-cadherin-repressed hNanos1 gene induces tumor cell invasion by upregulating MT1-MMP expression
Bonnomet, A., Polette, M., Strumane, K., Gilles, C., Dalstein, V., Kileztky, C., Berx, G., Roy, F. M. V., Birembaut, P. L., & Nawrocki‐Raby, B. (2008) · Oncogene · doi:10.1038/sj.onc.1211035 · Cited by 40
Self-citationPereira, P. S., Teixeira, A., Pinho, S., Ferreira, P. M. P., Fernandes, J., Oliveíra, C., Seruca, R., Suriano, G., & Casares, F. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl093 · Cited by 39
Strumane, K., Bonnomet, A., Stove, C. P., Vandenbroucke, R. E., Nawrocki‐Raby, B., Bruyneel, E. A., Mareel, M., Birembaut, P. L., Berx, G., & Roy, F. M. V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3096 · Cited by 37
Self-citationDames, S. A., Bang, E., Häußinger, D., Ahrens, T., Engel, J., & Grzesiek, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708335200 · Cited by 33
The Role of VHL in the Regulation of E-Cadherin: A New Connection in an Old Pathway
Russell, R. C., & Ohh, M. (2007) · Cell Cycle · doi:10.4161/cc.6.1.3668 · Cited by 27
Yan, Q., Zhang, Z., Chen, X., Gutmann, D. H., Xiong, M., Xiao, Z., & Huang, Z. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.5.1057 · Cited by 22
Effect of N‐cadherin misexpression by the mammary epithelium in mice
Knudsen, K. A., Sauer, C., Johnson, K. R., & Wheelock, M. J. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20469 · Cited by 21
TGF-β antagonists: Why suppress a tumor suppressor?
Akhurst, R. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215970 · Cited by 7
Cited by
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
Self-citationCancer Invasion and the Microenvironment: Plasticity and Reciprocity
Friedl, P., & Alexander, S. (2011) · Cell · doi:10.1016/j.cell.2011.11.016 · Cited by 1,940
Loh, C.-Y., Chai, J., Tang, T., Wong, W., Sethi, G., Shanmugam, M., Chong, P., & Looi, C. (2019) · Cells · doi:10.3390/cells8101118 · Cited by 1,315
Adherens junctions: from molecules to morphogenesis
Harris, T. J. C., & Tepass, U. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2927 · Cited by 990
Metadata
- Authors
- Berx, G., & van Roy, F.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2009-09-23
- Volume
- 1
- Issue
- 6
- Pages
- a003129-a003129
- ISSN
- 1943-0264 (ISSN-L)
- OpenAlex
- W2125970092
- Cited by
- 709
- References
- 190
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.